Trizol reagent drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (11)
Papers in which this entity is mentioned.
- Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics. (2026)
- Synchronized long-read genome, methylome, epigenome and transcriptome profiling resolve a Mendelian condition. (2025)
- MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. (2025)
- Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
- ESPRESSO: Robust discovery and quantification of transcript isoforms from error-prone long-read RNA-seq data. (2023)
- Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
- Exposure to ethanol leads to midfacial hypoplasia in a zebrafish model of FASD via indirect interactions with the Shh pathway. (2021)
- Reciprocal monoallelic expression of ASAR lncRNA genes controls replication timing of human chromosome 6. (2020)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
- Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. (2018)
- PVT1 dependence in cancer with MYC copy-number increase. (2014)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| trizol reagent | drug | 40 | 44 |